Acetyl-lysine binding site of bromodomain-containing protein 4 (BRD4) interacts with diverse kinase inhibitors.
Acetyl-lysine binding site of bromodomain-containing protein 4 (BRD4) interacts with diverse kinase inhibitors.
复制标题
DOI:
10.1021/cb500072z
复制
发表时间:
2014-05-16
影响因子:
4
通讯作者:
Schoenbrunn, Ernst
中科院分区:
文献类型:
--
作者:
Ember, Stuart W. J.;Zhu, Jin-Yi;Olesen, Sanne H.;Martin, Mathew P.;Becker, Andreas;Berndt, Norbert;Georg, Gunda I.;Schoenbrunn, Ernst
Members of the bromodomain and extra terminal (BET) family of proteins are essential for the recognition of acetylated lysine (KAc) residues in histones and have emerged as promising drug targets in cancer, inflammation, and contraception research. In co-crystallization screening campaigns using the first bromodomain of BRD4 (BRD4-1) against kinase inhibitor libraries, we identified and characterized 14 kinase inhibitors (10 distinct chemical scaffolds) as ligands of the KAc binding site. Among these, the PLK1 inhibitor BI2536 and the JAK2 inhibitor TG101209 displayed strongest inhibitory potential against BRD4 (IC50 = 25 nM and 130 nM, respectively) and high selectivity for BET bromodomains. Comparative structural analysis revealed markedly different binding modes of kinase hinge-binding scaffolds in the KAc binding site, suggesting that BET proteins are potential off-targets of diverse kinase inhibitors. Combined, these findings provide a new structural framework for the rational design of next-generation BET-selective and dual-activity BET-kinase inhibitors.
登录
查看更多内容
影响因子:
3.7
作者:
Krueger BJ;Varzavand K;Cooper JJ;Price DH
通讯作者:
Price DH
影响因子:
64.5
作者:
Matzuk MM;McKeown MR;Filippakopoulos P;Li Q;Ma L;Agno JE;Lemieux ME;Picaud S;Yu RN;Qi J;Knapp S;Bradner JE
通讯作者:
Bradner JE
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
14.8
作者:
Knapp, Stefan;Arruda, Paulo;Zuercher, William J.
通讯作者:
Zuercher, William J.
DOI:
10.1124/jpet.106.109058
发表时间:
2006-12-01
影响因子:
3.5
作者:
Braselmann, Sylvia;Taylor, Vanessa;Masuda, Esteban S.
通讯作者:
Masuda, Esteban S.